It is a wholly-owned subsidiary of Amy Bio. Dalian Hanxin changed its name to Amy Bio and is now a wholly-owned subsidiary of Amy Bio. Aimei Bio is a third-party partner of leading vaccine manufacturers in the world and China, promoting its services in China. Some of the shareholders behind it are private investors, who have made arrangements before listing and plans for the next three years.